You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,246,714


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,246,714
Title: Drug preparation
Abstract:Controlled release preparation containing a number of insoluble beads applied with one or more pharmaceutically active compounds, a method for the production thereof and the use in a treatment where a controlled release of a pharmaceutically active compound is needed.
Inventor(s): Dahlinder; Lars-Erik D. (Molndal, SE), Johansson; Mats O. (Goteborg, SE), Sandberg; John A. (Molndal, SE), Sjogren; John A. (Molnlycke, SE)
Assignee: Aktiebolaget Hassle (Molndal, SE)
Application Number:07/884,476
Patent Claim Types:
see list of patent claims
Compound; Delivery; Process;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 5,246,714: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the details of United States Patent 5,246,714, providing a thorough analysis of its scope, claims, and the broader patent landscape.

Background of the Patent

United States Patent 5,246,714, titled "Controlled Release Means," was granted to its inventors for a specific innovation in the field of pharmaceuticals. To analyze this patent, we need to understand its context, claims, and the technological area it pertains to.

Patent Search and Retrieval

To begin, one can use the USPTO's Patent Public Search tool or other resources like the Patent and Trademark Resource Centers (PTRCs) to retrieve the patent details. The Patent Public Search tool provides enhanced access to prior art and allows users to search through issued patents and published patent applications[1].

Patent Claims

The claims section of a patent is the most critical part, as it defines the scope of the invention. For US Patent 5,246,714, the claims would outline the specific controlled release means described in the patent. Here are some key points to consider:

Independent Claims

Independent claims are standalone claims that do not rely on other claims. They define the broadest scope of the invention. For example, Claim 1 might describe the overall controlled release system, including its components and how they interact.

Dependent Claims

Dependent claims build upon independent claims and provide more specific details. These claims narrow down the scope by adding additional features or limitations. For instance, Claim 2 might specify a particular material used in the controlled release system.

Claim Construction

Understanding the claim construction is vital. This involves interpreting the language used in the claims to determine the exact scope of protection. The USPTO's Patent Claims Research Dataset can provide insights into claim-level statistics and document-level statistics, which can be useful in analyzing claim construction trends[3].

Patent Scope

The scope of a patent is defined by its claims but also influenced by the description and drawings provided in the patent specification. Here’s how to analyze the scope:

Description and Drawings

The description section explains the invention in detail, including its background, summary, and detailed description. The drawings illustrate the invention and help in understanding its components and how they work together.

Prior Art

Prior art refers to existing knowledge and inventions in the field that predate the patent application. The Common Citation Document (CCD) application can be used to consolidate prior art cited by multiple patent offices, helping to understand the novelty and non-obviousness of the invention[1].

Technological Context

Understanding the technological context in which the patent was granted is essential. For US Patent 5,246,714, the controlled release means are likely part of the broader field of pharmaceutical delivery systems.

Industry Trends

The pharmaceutical industry is constantly evolving, with advancements in drug delivery systems being a significant area of innovation. The patent landscape in this field is dynamic, with numerous patents being filed and granted each year.

International Perspective

To see if similar inventions have been patented abroad, one can search international patent databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO)[1].

Legal and Litigation Aspects

Patents can be involved in litigation, and understanding the legal landscape is crucial.

Patent Infringement

The GAO report on patent infringement litigation highlights that certain types of patents, such as those related to software, are more likely to be involved in litigation. For pharmaceutical patents like US 5,246,714, the likelihood of litigation may be lower but still significant[4].

Patent Quality and Examination

The USPTO has initiatives to improve patent quality and examination. Linking trends in patent infringement litigation to internal data on patent examination can help in enhancing the quality of issued patents[4].

Practical Applications and Impact

The controlled release means described in US Patent 5,246,714 have practical applications in the pharmaceutical industry.

Benefits

Controlled release systems can improve drug efficacy, reduce side effects, and enhance patient compliance. These benefits are significant in the healthcare sector.

Market Impact

The market impact of such a patent can be substantial, influencing the development of new drugs and treatment methods. Companies holding such patents can have a competitive edge in the market.

Conclusion

Analyzing the scope and claims of US Patent 5,246,714 involves a detailed review of its claims, description, and drawings, as well as an understanding of the broader patent landscape and technological context.

Key Takeaways

  • Claims Analysis: Understand the independent and dependent claims to define the scope of the invention.
  • Prior Art: Use tools like the CCD to consolidate prior art citations.
  • Technological Context: Consider industry trends and international perspectives.
  • Legal Aspects: Be aware of potential litigation and initiatives to improve patent quality.
  • Practical Applications: Recognize the benefits and market impact of the invention.

FAQs

Q: How can I search for a specific patent like US 5,246,714?

A: You can use the USPTO's Patent Public Search tool or visit a Patent and Trademark Resource Center (PTRC) to search for and retrieve the patent details[1].

Q: What is the significance of the claims section in a patent?

A: The claims section defines the scope of the invention and is the most critical part of the patent. It outlines what is protected by the patent[3].

Q: How can I determine the prior art related to a patent?

A: Use the Common Citation Document (CCD) application to consolidate prior art citations from multiple patent offices[1].

Q: What are the practical applications of a controlled release system like the one described in US 5,246,714?

A: Controlled release systems can improve drug efficacy, reduce side effects, and enhance patient compliance in the pharmaceutical industry.

Q: How does the USPTO improve patent quality and examination?

A: The USPTO links trends in patent infringement litigation to internal data on patent examination to enhance the quality of issued patents and the examination process[4].

Sources

  1. USPTO: Search for patents - USPTO. (2018, October 18).
  2. PubChem: Controlled release means - Patent US-4975284-A - PubChem.
  3. USPTO: Patent Claims Research Dataset - USPTO. (2017, August 28).
  4. GAO: Assessing Factors That Affect Patent Infringement Litigation. (2013, August 22).

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,246,714

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,246,714

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden8504720Oct 11, 1985

International Family Members for US Patent 5,246,714

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 62409 ⤷  Subscribe
Austria 65391 ⤷  Subscribe
Australia 588630 ⤷  Subscribe
Australia 593038 ⤷  Subscribe
Australia 6317186 ⤷  Subscribe
Australia 6529686 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.